Found 6 matching trials
Radiotherapy Followed by Tiselizumab Combined With RCHOP in Previously Untreated Bulky Follicular Lymphoma
PHASE2This was a single center, single arm, phase II study. Patients with previou...
Location
Tianjin Cancer Hospital
Tislelizumab Combined With Anlotinib and 2-cycles Irinotecan as Second Line Treatment of SCLC
NASCLC has short doubling time, high proliferation rate and early widespread ...
Location
Guangdong Provincial Hospital of Traditional Chinese Medicine
A Study of IMM01 Plus Tiselizumab Versus Physician's Choice Chemotherapy in PD(L)1-refractory Classical Hodgkin Lymphoma
PHASE3The purpose of this study is to compare efficacy of IMM01 plus Tiselizumab ...
Location
Multiple Locations
A Trial of Pamiparib With Tislelizumab in Patients With Advanced Tumours With Homologous Recombination Repair Defects
PHASE2This study will describe the efficacy of pamiparib in combination with tisl...
Location
St Vincent's Hospital
Anti-HER2 Bispecific Antibody Zanidatamab (ZW25) Activity in Combination With Chemotherapy With/Without Tislelizumab
PHASE1The purpose of the study is to assess the safety, tolerability and prelimin...
Location
The Affiliated Hospital of Military Medical Sciences
A Study of QL1706 in Combination With Chemotherapy in PD-L1-Negative Non-small Cell Lung Cancer
PHASE3The purpose of this study is to evaluate the efficacy and safety of QL1706 ...
Status
Active Not Recruiting
Location
Sun Yat-sen University Cancer Center